P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
About this item
Full title
Author / Creator
Lantero‐Rodriguez, Juan , Snellman, Anniina , Benedet, Andrea L , Milà‐Alomà, Marta , Camporesi, Elena , Montoliu‐Gaya, Laia , Ashton, Nicholas J , Vrillon, Agathe , Karikari, Thomas K , Gispert, Juan Domingo , Salvadó, Gemma , Shekari, Mahnaz , Toomey, Christina E , Lashley, Tammaryn L , Zetterberg, Henrik , Suárez‐Calvet, Marc , Brinkmalm, Gunnar , Rosa Neto, Pedro and Blennow, Kaj
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Alzheimer’s disease (AD) is characterised by a long preclinical phase. Although phosphorylated tau (p‐tau) species such as p‐tau217 and p‐tau231 provide accurate detection of early pathological changes, other biomarkers capable of staging disease progression during preclinical AD are still needed. Combining exploratory and targeted mass spectrometr...
Alternative Titles
Full title
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
Authors, Artists and Contributors
Author / Creator
Snellman, Anniina
Benedet, Andrea L
Milà‐Alomà, Marta
Camporesi, Elena
Montoliu‐Gaya, Laia
Ashton, Nicholas J
Vrillon, Agathe
Karikari, Thomas K
Gispert, Juan Domingo
Salvadó, Gemma
Shekari, Mahnaz
Toomey, Christina E
Lashley, Tammaryn L
Zetterberg, Henrik
Suárez‐Calvet, Marc
Brinkmalm, Gunnar
Rosa Neto, Pedro
Blennow, Kaj
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a5fc24b2a60148e8ada0fe84e8c1fdbc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a5fc24b2a60148e8ada0fe84e8c1fdbc
Other Identifiers
ISSN
1757-4676,1757-4684
E-ISSN
1757-4684
DOI
10.15252/emmm.202115098
